Human UBAP1 activation kit by CRISPRa

CAT#: GA109693

UBAP1 CRISPRa kit - CRISPR gene activation of human ubiquitin associated protein 1



  See Other Versions

CNY 12255.00


货期*
4周

规格
    • 1 kit

Product images

推荐一起购买 (3)
Rabbit Polyclonal Anti-UBAP1 Antibody
    • 100 ul

CNY 1999.00
CNY 3280.00


UBAP1 (Myc-DDK-tagged)-Human ubiquitin associated protein 1 (UBAP1), transcript variant 1
    • 10 ug

CNY 3736.00
CNY 3990.00


UBAP1 Antibody - C-terminal region
    • 50 ug

CNY 4628.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol UBAP1
Locus ID 51271
Kit Components

GA109693G1, UBAP1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA109693G2, UBAP1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA109693G3, UBAP1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_001171201, NM_001171202, NM_001171203, NM_001171204, NM_016525, NR_033243
Synonyms NAG20; UAP; UBAP; UBAP-1
Summary This gene is a member of the UBA domain family, whose members include proteins having connections to ubiquitin and the ubiquitination pathway. The ubiquitin associated domain is thought to be a non-covalent ubiquitin binding domain consisting of a compact three helix bundle. This particular protein originates from a gene locus in a refined region on chromosome 9 undergoing loss of heterozygosity in nasopharyngeal carcinoma (NPC). Taking into account its cytogenetic location, this UBA domain family member is being studies as a putative target for mutation in nasopharyngeal carcinomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...